Statistics for Lucid Diagnostics (id:6893 LUCD)

Valuation metrics

Market cap

49.34M

Enterprise value

97.87M

Trailing P/E (ttm)

-0.79

Forward P/E

-1.45

PEG ratio

-1.45

Price/Sales (ttm)

12.99

Price/Book (mrq)

3.02

Enterprise Value/Revenue

25.76

Enterprise Value/EBITDA

-2.30

Overview

Shares outstanding

49.34M

Float

18.93M

Shares short

422.42K

% Held by insiders

0.65%

% Held by institutions

0.04%

Average volume (10 days)

390.48K

Average volume (90 days)

Price summary

52-Week low

0.63

52-Week high

1.58

52-Week change

-36.00%

Beta

1.42

50-Day moving average

0.85

200-Day moving average

0.93

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-146.25%

Operating margin

-1,146.72%

Operational effectiveness

Return on assets

-72.72%

Return on equity

-300.52%

Income statement

Revenue (ttm)

0.09

Revenue per share (ttm)

0.09

Quarterly revenue growth (yoy)

Gross profit (ttm)

-3,551,000.00

EBITDA

-42,581,000.00

Net income to common (ttm)

-54,151,000.00

Diluted EPS (ttm)

-1.21

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

26.28M

Total cash per share (mrq)

0.49

Total debt (mrq)

14.24M

Total Debt/Equity (mrq)

89.10

Current ratio (mrq)

174.90%

Book value per share (mrq)

-0.75

Cash flow

Cash flow statement

-42,854,000.00

Levered free cash flow (LFCF)

-33,013,750.00